In 2016, Barkan was a young husband and father and a rising star among progressive activists when he was diagnosed with the neurological disease called amyotrophic lateral sclerosis, or ALS. It's also commonly known as Lou Gehrig's disease and leads to the rapid loss of motor function and often early death.
Paul Miracle, 68, of Franklin, describes himself as a huge Bengals fan. He is often decked out in orange and black from head to toe, and his house is appropriately decorated with team memorabilia.
“No doubt in my mind, this is the year for Cincinnati,” Paul said.
The new drug, which is most effective on people who suffer with higher levels of chronic inflammation, stalls the progression of the degenerative neurological disease formally known as amyotrophic lateral sclerosis, or ALS, according to research published Monday in the journal Muscle & Nerve.
High-caloric interventions, including a high-caloric fatty supplement and a carbohydrate-rich high-caloric supplement, were able to induce weight gain in patients with amyotrophic lateral sclerosis (ALS). However, gastrointestinal (GI) symptoms and loss of appetite were the two common tolerability issues with high-fat and high-carbohydrate supplements, respectively.
Decades of research have failed to come up with a definite cause. However, one new study supports a link between playing professional football and ALS.
The application of Clinical Connectome Fingerprint (CCF) analysis to source-reconstructed magnetoencephalography (MEG) demonstrated the ability to assess the individual motor condition and its relationship with amyotrophic lateral sclerosis (ALS).
Due to the subject-specific characteristic of this technique, the authors hope that additional investigation pertinent to its clinical application may help make strides in diagnostic and therapeutic strategies of disease management.
Health experts say there is one early sign of ALS that could be clear when you're walking. Read on to find out what to watch out for on your next stroll.
Hard work definitely paid off for father-daughter duo Paul and Sarah Miracle. The pair is in Los Angeles to watch the Cincinnati Bengals play Super Bowl 56 — all thanks to generous donors.
For all the tears and sadness over Bridget Stegman's life-changing diagnosis, Friday morning was a celebration of the Jardine Elementary School educator.
Dozens of teachers lined the school's ramp, holding flowers and posters — some made by the children she's served — as tangible reflections of the love Stegman has put into her job as an instructional coach.
The HEALEY ALS Platform trial led by the Northeast ALS Consortium (NEALS) and the Healey & AMG Center for ALS at Massachusetts General Hospital is paving the way for rapid testing of potential treatments for people with amyotrophic lateral sclerosis (ALS), a neurodegenerative disease affecting the brain and spinal cord.